Rani Therapeutics Holdings, Inc. (RANI)
NASDAQ: RANI · Real-Time Price · USD
1.820
-0.270 (-12.92%)
At close: Oct 24, 2025, 4:00 PM EDT
1.849
+0.029 (1.60%)
After-hours: Oct 24, 2025, 7:59 PM EDT
RANI Stock Forecast
Stock Price Forecast
The 6 analysts that cover RANI stock have a consensus rating of "Strong Buy" and an average price target of $8.67, which forecasts a 376.37% increase in the stock price over the next year. The lowest target is $4.00 and the highest is $11.
Price Target: $8.67 (+376.37%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for RANI stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 5 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $11 | Strong Buy | Initiates | $11 | +504.40% | Oct 21, 2025 |
| Maxim Group | Maxim Group | Strong Buy Maintains $5 → $10 | Strong Buy | Maintains | $5 → $10 | +449.45% | Oct 20, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $14 → $4 | Buy | Maintains | $14 → $4 | +119.78% | May 16, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $9 | Strong Buy | Reiterates | $9 | +394.51% | Apr 3, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $9 | Strong Buy | Maintains | $9 | +394.51% | Feb 26, 2025 |
Financial Forecast
Revenue This Year
189.72K
from 1.03M
Decreased by -81.54%
Revenue Next Year
n/a
from 189.72K
EPS This Year
-0.55
from -1.05
EPS Next Year
-0.41
from -0.55
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 210,000 | n/a | |||
| Avg | 189,720 | n/a | |||
| Low | 168,560 | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -79.6% | - | |||
| Avg | -81.5% | - | |||
| Low | -83.6% | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -0.51 | -0.38 | |||
| Avg | -0.55 | -0.41 | |||
| Low | -0.58 | -0.44 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.